Bajaj Healthcare, a company in the Pharmaceuticals industry, reported revenue of ₹176 crore and net profit of ₹14 crore for the September 2026 quarter.
Bajaj Healthcare (NSE: BAJAJHCARE) closed at ₹320.15 on 20 Nov 2026, down 25.7% over the past year. Its market capitalisation is ₹1,078 crore and it trades at 18.5 times earnings.
Incorporated in 1993, Bajaj Healthcare Ltd manufactures a wide range of Active Pharmaceutical Ingredients and Formulations
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.